Anika Therapeutics (ANIK) Total Current Liabilities (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Total Current Liabilities of $22.1 million for Q2 2026, up 37.72% year-over-year from $16.1 million in Q2 2025, and up 5.63% quarter-over-quarter from $21.0 million in Q1 2026.
Anika Therapeutics (ANIK) Total Current Liabilities (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Total Current Liabilities for 17 consecutive years, with $22.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Current Liabilities rose 37.72% year-over-year to $22.1 million; the TTM figure through Jun 2026 stood at $22.1 million (up 37.72% YoY), while the FY2025 annual figure was $21.9 million, down 6.0% from the prior year.
- Total Current Liabilities improved to $22.1 million in Q2 2026 per ANIK's latest filing, from $21.0 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $31.1 million in Q4 2023 and bottomed at $16.1 million in Q2 2025.
- Historically, Total Current Liabilities has averaged $24.6 million across 5 years, with a median of $25.8 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities tumbled 42.54% — and 2026, when it surged 37.72%.
- Anika Therapeutics' Total Current Liabilities stood at $27.9 million in 2022, then rose by 11.27% to $31.1 million in 2023, then dropped by 24.96% to $23.3 million in 2024, then fell by 6.0% to $21.9 million in 2025, then climbed by 1.09% to $22.1 million in 2026.
- Business Quant data shows ANIK's Total Current Liabilities at $22.1 million in Q2 2026, $21.0 million in Q1 2026, and $21.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | 22.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.15 Mn |
| Mar 31, 2026 | 20.97 Mn |
| Dec 31, 2025 | 21.91 Mn |
| Sep 30, 2025 | 19.09 Mn |
| Jun 30, 2025 | 16.08 Mn |
| Mar 31, 2025 | 17.90 Mn |
| Dec 31, 2024 | 23.31 Mn |
| Sep 30, 2024 | 25.49 Mn |
| Jun 30, 2024 | 26.12 Mn |
| Mar 31, 2024 | 28.46 Mn |
| Dec 31, 2023 | 31.06 Mn |
| Sep 30, 2023 | 28.06 Mn |
| Jun 30, 2023 | 23.46 Mn |
| Mar 31, 2023 | 28.69 Mn |
| Dec 31, 2022 | 27.91 Mn |
| Sep 30, 2022 | 26.35 Mn |
| Jun 30, 2022 | 29.43 Mn |
| Mar 31, 2022 | 26.99 Mn |
| Dec 31, 2021 | 29.80 Mn |
| Sep 30, 2021 | 28.77 Mn |